Status:
COMPLETED
Effect of Electronic Monitoring and Feedback on Adherence to Easyhaler Controller Medication in Patients With Asthma
Lead Sponsor:
Orion Corporation, Orion Pharma
Conditions:
Asthma
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
Effect of Electronic Monitoring and Feedback on Adherence to Easyhaler Controller Medication in Patients with Asthma
Eligibility Criteria
Inclusion
- Main inclusion Criteria:
- written informed consent
- male and female subjects with documented diagnosis of asthma
- age 18 to 65 years
- ACT score 19 or less at screening
- treatment wih oral corticosteroids or hospital or emergency department admission due to asthma exacerbation within the past year
- subject's able to use Easyhaler inhalers and comply with study requirements
- Main exclusion Criteria:
- recent (within 1 month) asthma exacerbation
- concomitant major respiratory disease which may complicate the measurement of asthma control
- \>20 pack-year history of smoking
- recent upper or lower respiratory tract infection
- pregnant or lactating female subjects
Exclusion
Key Trial Info
Start Date :
June 23 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 24 2024
Estimated Enrollment :
158 Patients enrolled
Trial Details
Trial ID
NCT04869384
Start Date
June 23 2021
End Date
April 24 2024
Last Update
November 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MECS Research GmbH
Berlin, Germany